Reliance Chemotex Industries Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

Quality Assessment: Weak Fundamentals Persist

Despite the recent upgrade, Reliance Chemotex continues to exhibit weak fundamental quality. The company’s average Return on Capital Employed (ROCE) stands at a modest 9.25%, reflecting limited efficiency in generating returns from its capital base. Over the past five years, net sales have grown at a moderate annual rate of 7.89%, while operating profit has expanded at 19.57%. These figures indicate slow but steady growth, insufficient to inspire confidence in robust long-term expansion.

Moreover, the company’s ability to service debt remains a concern, with a high Debt to EBITDA ratio of 8.15 times. This elevated leverage ratio signals potential financial strain, especially in a volatile market environment. The flat financial performance in Q3 FY25-26, with net sales declining by 10.5% to ₹81.94 crores compared to the previous four-quarter average, further underscores the company’s operational challenges.

Valuation: Attractive but Reflective of Risks

On the valuation front, Reliance Chemotex presents a compelling case for value investors. The company’s ROCE of 4.5% combined with an Enterprise Value to Capital Employed ratio of 0.9 suggests it is trading at a discount relative to its peers. This undervaluation is further supported by a low PEG ratio of 0.2, indicating that the stock’s price is low compared to its earnings growth potential.

However, this attractive valuation is tempered by the company’s poor long-term growth prospects and financial risks. While profits have risen by 101.1% over the past year, the stock’s return over the same period was negative at -23.23%, reflecting market scepticism about the sustainability of earnings growth. Investors should be cautious, as the discount may be a reflection of underlying structural weaknesses rather than a pure value opportunity.

Financial Trend: Flat Performance Amidst Debt Concerns

The company’s recent quarterly results have been largely flat, with net sales for Q3 FY25-26 falling by 10.5% to ₹81.94 crores compared to the previous four-quarter average. This decline highlights ongoing operational challenges in a competitive textile industry. Over the last five years, the company’s sales and operating profit growth rates of 7.89% and 19.57% respectively, while positive, are not sufficient to offset concerns about its financial health.

Reliance Chemotex’s high Debt to EBITDA ratio of 8.15 times remains a significant red flag, indicating a low capacity to service debt. This financial leverage could constrain the company’s ability to invest in growth or weather economic downturns. The flat quarterly results and weak long-term fundamentals have contributed to the company’s underperformance relative to benchmarks, with a 1-year stock return of -23.23% compared to the Sensex’s near flat return of -0.04%.

Technical Analysis: Key Driver of Upgrade

The primary catalyst for the upgrade from Strong Sell to Sell is the improvement in technical indicators. The technical trend has shifted from bearish to mildly bearish, signalling a potential stabilisation in the stock’s price movement. Weekly MACD readings have turned mildly bullish, although monthly MACD remains bearish, suggesting mixed momentum across timeframes.

Other technical signals present a nuanced picture: the weekly KST (Know Sure Thing) indicator is mildly bullish, while the monthly KST remains bearish. Bollinger Bands show a weekly bearish stance but only mildly bearish on the monthly scale. Moving averages on a daily basis are mildly bearish, and Dow Theory assessments indicate a mildly bearish trend on both weekly and monthly charts. The On-Balance Volume (OBV) indicator shows no clear trend weekly and mildly bearish monthly.

Price action has been relatively stable, with the current price at ₹123.10, unchanged from the previous close. The stock’s 52-week range spans from ₹109.80 to ₹211.65, with today’s trading range between ₹121.40 and ₹131.00. Short-term returns have outperformed the Sensex, with a 1-week return of 3.88% versus 2.18% for the benchmark, and a 1-month return of 8.94% compared to 5.35% for the Sensex. However, longer-term returns remain disappointing, with a 3-year return of -31.06% against the Sensex’s 31.67%.

Market Position and Shareholding

Reliance Chemotex operates within the textile industry segment of the Garments & Apparels sector. It is classified as a micro-cap stock, reflecting its relatively small market capitalisation. The company’s majority shareholders are promoters, which often implies concentrated ownership and potential influence over strategic decisions.

Despite the recent technical improvements, the company’s long-term underperformance relative to the BSE500 index and the Sensex remains a concern. Over the past three years, Reliance Chemotex has consistently underperformed the benchmark indices, generating negative returns of -23.23% in the last year alone. This persistent underperformance highlights the challenges the company faces in regaining investor confidence.

Investment Outlook: Balanced but Cautious

The upgrade to a Sell rating from Strong Sell reflects a cautious optimism driven by technical improvements. While the stock shows signs of stabilisation in price momentum and short-term outperformance relative to the Sensex, fundamental weaknesses and financial risks persist. Investors should carefully consider the company’s flat recent financial results, high leverage, and long-term underperformance before committing capital.

Valuation metrics suggest the stock is attractively priced, but this discount appears to be a reflection of underlying risks rather than a clear value opportunity. The mixed technical signals warrant close monitoring, as a sustained improvement in momentum could pave the way for a more positive outlook. Until then, the Sell rating appropriately balances the modest technical gains against the company’s structural challenges.

Summary of Rating Changes

Reliance Chemotex’s Mojo Score currently stands at 31.0, with the Mojo Grade upgraded to Sell from Strong Sell on 20 Apr 2026. The upgrade was primarily triggered by a shift in technical grades from bearish to mildly bearish, supported by weekly MACD and KST indicators turning mildly bullish. However, the company’s quality grade remains weak due to low ROCE and high debt, while financial trends are flat and valuation remains attractive but risky.

Investors should weigh these four parameters—quality, valuation, financial trend, and technicals—when assessing the stock’s prospects. The technical improvement offers a glimmer of hope, but fundamental and financial challenges continue to weigh heavily on the company’s outlook.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →